The rising popularity of nuclear medicine imaging has spurred several organizations to develop DICOM standards for seamless transmission of the complex dynamic images in the digital world of PACS.The Society of Nuclear Medicine DICOM working group and
The rising popularity of nuclear medicine imaging has spurred several organizations to develop DICOM standards for seamless transmission of the complex dynamic images in the digital world of PACS.
The Society of Nuclear Medicine DICOM working group and the Integrating the Healthcare Enterprise (IHE) are jointly developing a nuclear medicine image profile.
"The clinician's window to the imaging world is the DICOM standard. If this window is small, dirty, and blurry, clinicians will not appreciate the value of our specialty," said Dr. Henry D. Royal, president of the SNM.
The profile has two major parts, said Dr. Jerold W. Wallis, an associate professor of radiology at the Mallinckrodt Institute of Radiology and chair of the working group. One involves educating PACS designers about the unique qualities of nuclear medicine image data to facilitate development of systems that can handle complex multiframe images, sometimes from different heads of the gamma camera or different energy windows as part of a multi-isotope study.
The second part of the profile outlines specific IHE compliance requirements for vendors. They include the ability to adjust upper and lower levels of gray-scale window settings, to show several cine images simultaneously, and to use customized logic to avoid showing postage stamp-sized images. These requirements were based on a previously published SNM guideline (J Nucl Med 2002;43:[10]1410-1413).
The profile also addresses cardiac nuclear medicine requirements, including the use of new cardiac DICOM codes to record a patient's state during acquisition and to differentiate short-axis from transaxial SPECT data, as well as the ability to apply local color tables to gray-scale nuclear medicine images.
Trial implementation of the profile began this summer. Participating vendors will add nuclear medicine features to an in-house version of their software. The next step will be an IHE connect-a-thon in January 2005, to which vendors can bring their systems for testing and validation.
"The number of participating vendors and the priority they give to this effort depends on consumer demand. It is up to the nuclear medicine community to ask vendors for the profile in order to push the process forward," Wallis said.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.
2 Commerce Drive
Cranbury, NJ 08512